Save this technology
close
Save to Existing Project
Save to a New Project
Cartexan® 400 Mg Hard Capsules - Chondroitin Sulfate
Bioiberica Spain flag Spain
Abstract ID:
Authorized and available for out-licensing in Italy and Czech Republic.
Contact Monica Gomez Navarro
RE:
Participants
You
Cartexan 400 mg hard capsules Chondroitin Sulfate is indicated for the symptomatic treatment of osteoarthritis of the hip and knee.

Currently authorized and commercialized as Rx in several countries of Europe (Finland, Austria, Hungary and Poland) 

Available for out-licensing in Italy and Czech Republic. 

CTD Dossier ready for registration.
Type of Business Relationship Sought
Out-licensing opportunity
FEATURED
Last Updated Mar 2017
Technology Type THERAPEUTIC
Phase of Development REGISTERED / FINISHED PRODUCT
CORPORATION

Opportunity Contact